Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunocore Holdings Plc ADR
(NQ:
IMCR
)
37.20
-0.72 (-1.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Immunocore Holdings Plc ADR
< Previous
1
2
Next >
Immunocore reports second quarter financial results and provides a business update
August 08, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore to report second quarter 2024 financial results and host call on August 8, 2024
August 01, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma
June 18, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
June 01, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024
May 31, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore to present at the Jefferies Global Healthcare Conference
May 30, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma
May 29, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore reports first quarter financial results and provides a business update
May 08, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore announces upcoming presentation and posters at ASCO 2024
April 24, 2024
From
Immunocore Holdings plc
Via
GlobeNewswire
Immunocore to present at upcoming investor conferences
April 04, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore presented two posters at CROI 2024
March 05, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at upcoming investor conferences
March 01, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
February 28, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial
February 22, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024
February 21, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Prices Upsized Convertible Senior Notes Offering
January 30, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Announces Proposed Convertible Senior Notes Offering
January 29, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
January 05, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update
November 07, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023
November 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at upcoming investor conferences
October 30, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial
October 21, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore announces upcoming presentation and posters at ESMO 2023
October 06, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at upcoming investor conferences
September 11, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Institutions are Buying These 3 Stocks and Analysts Agree
September 07, 2023
Rumble (RUM), Immunocore (IMCR), and STMicroelectronics (STM) are attracting increased institutional interest, presenting potential investment opportunities.
Via
MarketBeat
Immunocore to present at upcoming investor conferences
September 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to report second quarter 2023 financial results and host call on August 10, 2023
August 03, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
June 03, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit